EBRO 2017
Chemoradiotherapy compensates for poor surgery? Gastric cancer adjuvant chemoradiation
EBRO 2017
A meta-analysis (n=2811)
No benifit on Overall Survivial in D2 subgroup
D0
D1
D2
Ohri et al. IJROBP 2013
Made with FlippingBook Learn more on our blog